Current Clinical Trials

Our current clinical trials explore new, as well as existing, medical therapies which will improve glucose control in people with Diabetes.

All study-related care, diabetes education and medications are provided at no charge. Medical insurance is not neccessary for study participation.

The average duration of a clinical trial is 6-12 months.

The benefits of participation in a clinical trial include intensive management of your Diabetes; access to the most recent advances in investigational therapy; close, personalized follow-up by a board-certified endocrinologist; and the opportunity to help in the development of improved therapies for the management of Diabetes.

Type 1 Diabetes

We are have participated in many interesting studies designed to evaluate new treatment options for people with Type 1 Diabetes treated with injections as well as those treated with insulin pumps.

Oral and injectable investigational medications are being studied at our center.

We'll begin recruitment in August 2020 for a trial evaluating a a long-acting insulin receptor agonist that will be compared with insulin degludec in people with T1 who are being treated with multiple daily injections.

Please call our office at 301-770-7373 for further information.

Type 2 Diabetes

There are currently multiple ongoing clinical trials in our research center actively enrolling subjects with Type 2 Diabetes.

Trials will evaluate people with Type 2 Diabetes who are currently treated with pills or insulin.

Several trials include investigational treatments which, in addition to improving sugar control, are associated with weight loss.

Another trial will study a very rapid acting meal time insulin

This is a link for the SURPASS CV outcome trial.

There is also a link in the Clinical Trials section.

We're excited about the opportunities for improved glucose control that each of these trials offer to people with diabetes.

Please call us to review trials which will begin recruitment in September and August.

Atherosclerotic Disease and Obesity without diabetes

We're recruiting subjects for the SELECT Trial, a study evaluating the effects of semaglutide on CV outcomes in people who are overweight and have a history of heart attack, stroke or PVD.  This is a long-term, outcomes study.

There is a link for this trial in the Clinical Trials section.

Please call our office at 301-770-7373 for details regarding current clinical trials as well as upcoming trial opportunities which may not be posted on our website.

Please also visit our "Commonly asked Questions " page for general trial related questions.